Skip to main content
. Author manuscript; available in PMC: 2020 May 29.
Published in final edited form as: J Am Coll Cardiol. 2019 Oct 22;74(16):2074–2084. doi: 10.1016/j.jacc.2019.07.083

Table 1.

Demographic and clinical characteristics of patients with or without MACE at 5 years and of patients with or without angina at 1 year

Major Adverse Cardiovascular Events at 5 years Any Angina at 1 year*
Yes No P-value Yes No P-value
n=346 n=1554 n=310 n=1353
Assigned to CABG arm 146 (42.2%) 801 (51.5%) 0.001 134 (43.2%) 677 (50.0%) 0.030
Age (y) 64.9 ± 9.7 62.7 ± 8.9 < 0.001 62.2 ± 9.1 63.1 ± 8.9 0.107
Age groups < 0.001 0.214
 < 50 22 (6.4%) 122 (7.9%) 28 (9.0%) 98 (7.2%)
 50–59 80 (23.1%) 466 (30.0%) 97 (31.3%) 383 (28.3%)
 60–69 124 (35.8%) 617 (39.7%) 108 (34.8%) 555 (41.0%)
 >=70 120 (34.7%) 349 (22.5%) 77 (24.8%) 317 (23.4%)
Male 243 (70.2%) 1113 (71.6%) 0.604 201 (64.8%) 999 (73.8%) 0.001
White race 269 (77.7%) 1182 (76.1%) 0.517 247 (79.7%) 1024 (75.7%) 0.135
Body mass index (kg/m2) 29.5 ± 5.7 29.8 ± 5. 0.306 30.0 ± 5.7 29.7 ± 5.2 0.347
History of smoking 65 (18.8%) 233 (15.0%) 0.027 51 (16.5%) 207 (15.3%) 0.436
Prior myocardial infarction 106 (30.6%) 381 (24.5%) 0.018 70 (22.6%) 345 (25.5%) 0.284
Prior cerebrovascular event 24 (6.9%) 41 (2.6%) < 0.001 12 (3.9%) 39 (2.9%) 0.362
History of peripheral vascular disease 35 (12.5%) 161 (9.9%) 0.201 27 (8.7%) 141 (10.4%) 0.367
Chronic lung disease 21 (6.1%) 62 (4.0%) 0.086 10 (3.2%) 55 (4.1%) 0.491
Recent acute coronary syndrome 121 (35.0%) 462 (29.7%) 0.055 84 (27.1%) 422 (31.2%) 0.157
Three vessel disease 298 (87.1%) 1275 (82.5%) 0.038 254 (81.9%) 1121 (83.4%) 0.532
On insulin 148 (42.8%) 467 (30.1%) < 0.001 109 (35.2%) 410 (30.3%) 0.095
LVEF (%) 55.8 ± 13.1 59.0 ± 11.2 < 0.001 59.9 ± 11.4 58.7 ± 11.3 0.090
Hemoglobin (g/dL) 13.3 ± 1.9 13.8 ± 1.6 < 0.001 13.5 ± 1.7 13.8 ± 1.6 0.006
Hemoglobin A1C < 7 g/dL 99 (31.4%) 531 (37.0%) 0.060 101 (36.7%) 465 (36.7%) 0.986
eGFR MDRD, mL/min/1.73 m2 63.6 ± 19.8 70.9 ± 17.4 < 0.001 69.1 ± 17.6 70.6 ± 17.8 0.176
Euroscore 3.4 ± 3.0 2.5 ± 2.3 < 0.001 2.5 ± 2.1 2.6 ± 2.3 0.606
SYNTAX score 0.006 0.399
 Mean 27.3 ± 8.6 25.9 ± 8.6 25.8 ± 8.4 26.3 ± 8.6
 Median (interquartile range) 26.0 (21.0, 32.0) 26.0 (19.8, 31.0) 26.0 (19.0, 31.0) 26.0 (20.0, 31.5)
SYNTAX score >22 238 (68.8%) 987 (63.5%) 0.063 198 (63.9%) 880 (65.0%) 0.697
Number of antianginal medications 1.5 ± 0.9 1.5 ± 0.9 0.489 1.5 ± 0.9 1.4 ± 0.9 0.825
Angina frequency 0.177 < 0.001
 Daily/Weekly 96 (34.5%) 593 (37.0%) 156 (50.8%) 446 (33.1%)
 Monthly 127 (45.7%) 639 (39.9%) 116 (37.8%) 556 (41.2%)
 No Angina 55 (19.8%) 369 (23.0%) 35 (11.4%) 346 (25.7%)
SAQ Angina Frequency 72.0 ± 23.8 71.0 ± 25.1 0.491 62.3 ± 26.2 73.4 ± 24.2 < 0.001
*

Data on angina frequency at 1 year was missing in 237 patients